Fingerprint
Dive into the research topics of 'Bortezomib, bendamustine,and rituximab in patients with relapsed or refractory follicular lymphoma: The phase II vertical study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Bortezomib, bendamustine,and rituximab in patients with relapsed or refractory follicular lymphoma: The phase II vertical study
Nathan Fowler, Brad S. Kahl, Peter Lee, Jeffrey V. Matous, Amanda F. Cashen, Samuel A. Jacobs, Jeffrey Letzer, Bipinkumar Amin, Michael E. Williams, Sonali Smith, Alfred Saleh, Peter Rosen, Hongliang Shi, Sudha Parasuraman, Bruce D. Cheson
Research output: Contribution to journal › Article › peer-review
91
Scopus
citations